Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sedwick Wd is active.

Publication


Featured researches published by Sedwick Wd.


Advances in Enzyme Regulation | 1984

The occurrence and consequences of deoxyuridine in DNA.

Richards Rg; L.C. Sowers; John Laszlo; Sedwick Wd

Deoxyuridine can become resident in the DNA of prokaryotic and eukaryotic cells via two general mechanisms - deamination of cytosine to uracil, and nucleotide pool changes that lead to misincorporation of deoxyuridine in place of thymidine. In this paper we have examined the chemical basis of deamination reactions in DNA and discussed a possible mechanism for an increased rate of deamination by means of cross-strand protonation of cytosine by alkylated guanine. In addition, we have examined the genetic and drug-induced conditions that lead to dUMP misincorporation into DNA in place of thymidine and have presented experimental evidence indicating that the antifolate-induced lesion is a general drug-dose dependent lesion of human blood cells. Finally, the toxic and genetic impact of this lesion has been evaluated within the context of a review of the repair mechanisms elicited by dUMP in DNA.


Proceedings of the National Academy of Sciences of the United States of America | 1981

Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA: inhibition of high molecular weight DNA synthesis in human lymphoblastoid cells

Sedwick Wd; Marc Kutler; Oliver E. Brown


Molecular Pharmacology | 1982

Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.

Sedwick Wd; Hamrell M; Oliver E. Brown; John Laszlo


Molecular Pharmacology | 1979

Deoxyuridine incorporation as a useful measure of methotrexate and metoprine uptake and metabolic effectiveness.

Sedwick Wd; Fyfe Mj; Oliver E. Brown; T. Frazer; Marc Kutler; John Laszlo


Basic life sciences | 1985

Misincorporation of Deoxyuridine in Human Cells: Consequences of Antifolate Exposure

Richards Rg; O. E. Brown; Sedwick Wd


Molecular Pharmacology | 1981

Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line

Hamrell M; John Laszlo; Oliver E. Brown; Sedwick Wd


Molecular Pharmacology | 1986

Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U)

Richards Rg; O. E. Brown; Maura L. Gillison; Sedwick Wd


Molecular Pharmacology | 1981

Transient Induction of Phenotypic Resistance in Human Lymphoblastoid Cells following Sequential Use of Two Antifolates

Hamrell M; John Laszlo; Sedwick Wd


Archive | 1979

Transport of antifolate in human leukocytes: Effects of media

M. J. Fyfe; John Laszlo; Oliver E. Brown; Sedwick Wd


Federation Proceedings | 1978

Antifolate inhibition of deoxyuridine incorporation in human lymphoblastoid cell lines: relationship of exogenous thymidine and deoxyuridine concentrations

Sedwick Wd; Oliver E. Brown; T. Frazer

Collaboration


Dive into the Sedwick Wd's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge